48 results
Page 2 of 3
6-K
EX-99.1
jkoo8
22 Sep 22
Current report (foreign)
4:42pm
6-K
EX-99.1
jmz8qccz586d3im 09
8 Sep 22
Medicenna to Present at Investor and Scientific Conferences in September
5:19pm
SUPPL
m4gc7h
10 Aug 22
Supplemental materials (foreign)
3:10pm
SUPPL
g7pnh6
8 Aug 22
Supplemental materials (foreign)
8:40pm
20-F
EX-15.1
klhylu3vab50tqca815c
22 Jun 22
Annual report (foreign)
5:04pm
20-F
nrhtk4v
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.3
ih8mhcyuzgnpe1mh
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.1
qx6n08kw9xqb0zhj73xo
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.1
mc0hd66
22 Jun 22
Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights
7:15am
6-K
EX-99.1
csdr9 qm2
3 Mar 22
Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor
7:10am
6-K
EX-99.2
69srhl jso3a9pbz
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
EX-99.5
hwejhk
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
EX-99.1
z8v66avab6t4x
18 Nov 21
Current report (foreign)
7:15am
6-K
EX-99.5
utgw0 rr68
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
40-F
EX-99.3
92usb
28 May 21
Annual report (Canada)
12:12pm
40-F
EX-99.1
en9rfhxv981j
28 May 21
Annual report (Canada)
12:12pm
6-K
EX-99.1
7yieqo8 yungh64hd
28 May 21
Medicenna Reports Fiscal Year 2021 Financial Results and Operational Highlights
7:40am
SUPPL
zdksuto
30 Dec 20
Supplemental materials (foreign)
5:28pm
6-K
EX-99.1
l4lboky01aclfmm73e68
2 Dec 20
Medicenna Hosting Key Opinion Leader Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme
8:44am
6-K
EX-99.1
nrer3o7
18 Nov 20
Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting
7:21am